About FDA
Number of OE-recommended and posted health fraud internet site warning letters
Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.
Information is current as of February 12, 2013.
Fiscal Year - 2011
| Time | Target | Number of recommended WLs |
|---|---|---|
| Oct 2010 | N/A | 3 |
| Nov 2010 | N/A | 3 |
| Dec 2010 | N/A | 2 |
| Jan 2011 | N/A | 2 |
| Feb 2011 | N/A | 4 |
| Mar 2011 | N/A | 2 |
| Apr 2011 | N/A | 3 |
| May 2011 | N/A | 1 |
| Jun 2011 | N/A | 3 |
| Jul 2011 | N/A | 3 |
| Aug 2011 | N/A | 3 |
| Sep 2011 | N/A | 3 |
FY 2011 Total: 32
Percent of OE-recommended health fraud internet site warning letters approved by the Center for issuance and posting on FDA.gov
Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.
Fiscal Year - 2011
| Time | Target | Percent |
|---|---|---|
| Oct 2010 | 100 | 0 |
| Nov 2010 | 100 | 0 |
| Dec 2010 | 100 | 50 |
| Jan 2011 | 100 | 0 |
| Feb 2011 | 100 | 50 |
| Mar 2011 | 100 | 100 |
| Apr 2011 | 100 | 100 |
| May 2011 | 100 | 100 |
| Jun 2011 | 100 | 0 |
| Jul 2011 | 100 | 0 |
| Aug 2011 | 100 | 100 |
| Sep 2011 | 100 | 100 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
